anisodamine has been researched along with Coronary Thrombosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, WZ; Fan, YM; Fu, XH; Fu, Y; Gu, XS; Hao, GZ; Jiang, YF; Li, YJ; Wei, QM | 1 |
1 trial(s) available for anisodamine and Coronary Thrombosis
| Article | Year |
|---|---|
Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
Topics: Aged; Cardiac Catheterization; China; Coronary Circulation; Coronary Thrombosis; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Microcirculation; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Thrombectomy; Thrombolytic Therapy; Time Factors; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency | 2019 |